ANIP - Company ID 0001023024
ANI PHARMACEUTICALS INC trades as ANIP and has a market capitalization of $1.85 B, making it the #2207 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $883.37M, up 43.8% from the prior year and net income of $78.00M. This page tracks ANI PHARMACEUTICALS INC through 1,742 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-11
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years ANI PHARMACEUTICALS INC's revenue grew from $128.62M to $883.37M, a compound annual growth rate of 23.9%. Net profit margin expanded from 3.1% to 8.8% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-year
Record quarterly and full year net revenues of $247.1 million and $883.4 million, up 29.6% and 43.8% year-over-year, respectively
Record quarterly net revenues of $227.8 million, an increase of 53.6% year-over-year
Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basis
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4%
The largest companies sharing ANI PHARMACEUTICALS INC's SEC industry classification (pharmaceutical preparations).
ANI PHARMACEUTICALS INC (ANIP) has a market capitalization of $1.85 B as of 2026-07-11, ranking #2207 among US-listed companies.
ANI PHARMACEUTICALS INC reported revenue of $883.37M for fiscal year 2025, an increase of 43.8% year over year.
Yes. ANI PHARMACEUTICALS INC reported net income of $78.00M in its latest fiscal year.